Softgel Capsules Market Size Worth US$ 14.3 billion by 2030, Globally, to grow at a CAGR of 7.6% | Growth Plus Reports

News provided by

Jul 29, 2022, 09:00 ET

NEW YORK, July 29, 2022 /PRNewswire/ -- The global softgel capsules market is expected to clock ~US$ 14.3 billion by 2030 owing to the rising prevalence of chronic diseases and increased R&D investments by the key players, states Growth Plus Reports.

Growth Drivers

One of the main drivers of the global softgel capsules market is the penetration of new and innovative technologies by manufacturers and drug developers. Producers are starting a variety of R&D projects to provide unique empty softgel capsules, which are very convenient for the cosmeceutical, pharmaceutical, nutraceutical, and other market segments. The pharmaceutical and nutraceutical industries are becoming increasingly interested in empty softgel capsules. The unique qualities of empty softgel capsules for various formulations, such as solid and liquid dosage types, and easy-to-use features, while managing medications orally or through inhalation routes, are considerably driving the market demand for softgel capsules.

Get a Sample PDF of the Report – https://growthplusreports.com/inquiry/request-sample/softgel-capsules-market/7745

The global softgel capsules market has been analyzed from four different perspectives – Type, Application, Manufacturer, and Region.

Excerpts from 'By Type Segmentation'

Based on type, softgel capsules are subdivided into:

Gelatin
Non-Animal Based

Gelatin has been the most preferred raw material for the manufacturing of softgel capsules. Because of its unparalleled benefits such as patient compliance, easily digestible, mechanical resistance, abundant availability and inert nature, it is widely accepted by manufacturers. Gelatin that is extracted from cows and pork gives benefits such as firmness, plasticity and clarity to the capsules thus they are used together in the fabrication of capsules. In spite of all these advantages, non-animal-based capsules are anticipated to show a high growth rate in the forecast period. This is attributed to the inclination of the population toward vegan options, especially after the outbreak of the COVID-19 pandemic. Additionally, growing research activities and innovations such as the use of pea-starch technology in developing softgel capsules are likely to boost the growth of the global softgel capsules market.

Excerpts from 'By Manufacturer'

Based on manufacturers, the softgel capsules market is subdivided into:

Nutraceuticals
Pharmaceuticals
Cosmeceuticals

The nutraceuticals segment focuses primarily on the development of vitamins, minerals, and supplements. Therefore, softgel formulations are primarily developed to meet the growing demand for dietary supplements. Pharmaceutical companies have the second largest share of this segment due to increased collaboration with SMEs and outsourcing of softgel capsules. This had a direct impact on the growth of the Consignment Manufacturing Organization (CMO) segment. Increasing demand for skin and hair care products is driving the production of softgel capsules in the cosmeceuticals market.

Get a Sample Copy of the prefilled syringes Market Report 2022

Excerpts from 'By Region Segmentation'

The global softgel capsules market has been segmented into:

North America
Europe
Asia Pacific
Rest of the World

The market for starch softgel capsules in Europe is expected to grow manifolds in the forecast period. The growth of the European non-animals-based softgel market is due to the increasing availability of vegetarian softgels and the growing preference for softgels by pharmaceutical and dietary supplement companies. However, the difficulty of optimizing cellulose/starch for API delivery is hindering the market growth.

Germany is the largest market for starch softgel capsules due to the increased prevalence of chronic diseases and increased investment by market participants. For example, in April 2019, Catalent expanded its integrated turnkey softgel capabilities at its facility in Eberbach, Germany. The company invested ~USD 14 million in this expansion. This includes two new softgel encapsulation lines dedicated to the company's Vegicaps technology. This investment is driven by increasing demand for non-abuse consumer health products.

Excerpts from 'Competitive Landscape'

The prominent players operating in the global softgel capsules market are:

Fuji Capsules Co Ltd
Capsugel
Soft Gel Technologies Inc
Captek Softgel International Inc
Cloverty
Delpharm
Catalent
Aenova Group
Patheon
Eurocaps Ltd
Among others

Softgel Capsules Market Segmentation:

By Type Outlook

Gelatin Capsules
Non-animal Capsules

By Application Outlook

Health & Dietary Supplements
Prescribed Supplements

By Manufacturer Outlook

Nutraceuticals
Pharmaceuticals
Cosmeceuticals

Report Scope & Segmentation:

Report Coverage	Details
Market Size in 2021	USD ~ 7.4 billion
Revenue forecast in 2030	USD ~ 14.3 billion
Growth Rate	CAGR of ~ 7.6% from 2022 to 2030
Base year for estimation	2021
Forecast period	2022-2030
Segments covered	Type, Application, Manufacturer
Regional scope	North America, Europe, Asia Pacific, and the Rest of the World (ROW)

VALUE PROPOSITIONS RELATED TO THE REPORT:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Winning imperatives
Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

Distributor Landscape Assessment
Pricing Intelligence
Customer Base Assessment
Investment & Initiatives Analysis
'Business Profile' of Key Players

Speak to Our Expert: https://growthplusreports.com/inquiry/speak-analyst/softgel-capsules-market/7745

About Us:

Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

Contact:
Manan Sethi
Director, Market Insights
Email: [email protected]
Phone no: +91 96545 76783
Web: https://growthplusreports.com/
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/1671244/Growth_Plus_Reports_Logo.jpg

SOURCE Growth Plus Reports